Correction to [MAPK‐Targeted Drug Delivered by a pH‐Sensitive MSNP Nanocarrier Synergizes with PD‐1 Blockade in Melanoma Without T‐Cell Suppression]
In the initially published version of this article, the flow cytometer images of SMM103 cells in Figure 2F (a) and (b) were identical.This error occurred due to an incorrect "copy" and "paste" action during the figure organization.Below is the corrected Figure 2F.The correction does not affect any other results or the scientific conclusions.We apologize for this error.Figure 2. (F) Melanoma cells and lymphocytes were incubated with 50 g mL -1 (a) or 25 g mL -1 (b) FITC-labeled MSNP-PAA-PEG for 24, 48, and 72 h.The internalizations were determined by a flow cytometer.
Publication Details
- Journal
- Advanced Functional Materials
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1002/adfm.202425023
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00